Simon Pedder

2019 - Avalo Therapeutics

In 2019, Simon Pedder earned a total compensation of $3.8M as Former Executive Chairman of the Board at Avalo Therapeutics, a 13,562% increase compared to previous year.

Compensation breakdown

Bonus$157,500
Option Awards$1,855,965
Salary$247,917
Stock Awards$1,245,000
Other$270,267
Total$3,776,649

Pedder received $1.9M in option awards, accounting for 49% of the total pay in 2019.

Pedder also received $157.5K in bonus, $247.9K in salary, $1.2M in stock awards and $270.3K in other compensation.

Rankings

In 2019, Simon Pedder's compensation ranked 3,185th out of 13,971 executives tracked by ExecPay. In other words, Pedder earned more than 77.2% of executives.

ClassificationRankingPercentile
All
3,185
out of 13,971
77th
Division
Manufacturing
1,149
out of 5,695
80th
Major group
Chemicals And Allied Products
390
out of 2,194
82nd
Industry group
Drugs
320
out of 1,880
83rd
Industry
Pharmaceutical Preparations
236
out of 1,392
83rd
Source: SEC filing on April 28, 2020.

Pedder's colleagues

We found three more compensation records of executives who worked with Simon Pedder at Avalo Therapeutics in 2019.

2019

Pericles Calias

Avalo Therapeutics

Chief Scientific Officer

2019

Joseph Miller

Avalo Therapeutics

Chief Financial Officer

2019

Peter Greenleaf

Avalo Therapeutics

Chief Executive Officer

News

You may also like